Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Air Products & Chemicals, Inc. (APD) vs Alexandria Real Estate Equities Inc (ARE) Price & Performance

Air Products & Chemicals, Inc.Trade
Alexandria Real Estate Equities IncTrade

Price performance (Past 24H)

Key statistics

Air Products & Chemicals, Inc. vs Alexandria Real Estate Equities Inc — how do they compare? Air Products & Chemicals, Inc. trades at $305.67 (market cap $68.88B), while Alexandria Real Estate Equities Inc trades at $47.8 (market cap $8.28B). The key difference: Air Products & Chemicals, Inc. is far larger — about 8.3× Alexandria Real Estate Equities Inc's market cap, and Alexandria Real Estate Equities Inc pays the higher dividend (5.99%). Which is the better fit depends on your goals.

APDARE
Market Cap
$68.88B$8.28B
Sector
Basic MaterialsReal Estate
52-Week High
$314.19$87.45
52-Week Low
$230.42$40.41
Enterprise Value
$86.06B$20.98B
Dividend Yield
2.34%5.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Air Products & Chemicals, Inc.

Air Products and Chemicals (APD) trades at $308.18, up 1.56% with strong technical momentum and bullish moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 EPS of $3.47 exceeding expectations. Recent positive developments include a major semiconductor supply agreement in Taiwan and raised guidance, though profitability metrics show weakness with negative net income margin and ROE. Analyst consensus remains strongly bullish with a $346 price target representing 12% upside potential.

APD presents a growth opportunity driven by strategic contracts and consistent earnings beats, but faces fundamental challenges with negative profitability and elevated debt levels. The stock's technical strength and institutional support provide near-term momentum, though investors should weigh the disconnect between valuation multiples and current financial performance against the company's long-term growth prospects in industrial gases.

Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities (ARE) trades at $48.35, down 2.79% today, with a bearish technical signal and mixed fundamentals. The stock shows a negative net income margin of -37.12% for 2025, though recent Q2 2026 FFO beat estimates. Analyst consensus is a 'Buy' with a $53.71 price target, but technical indicators suggest near-term pressure with support at $47 and resistance at $50.

Outlook remains cautious due to profitability challenges and high debt, but leasing momentum and strategic partnerships offer recovery potential. Risks include ongoing net losses and market volatility, while institutional interest and dividend payments provide some stability. Investors should weigh fundamental weaknesses against long-term real estate sector recovery prospects.

Returns comparison

Trailing returns across standard periods

About Air Products & Chemicals, Inc.

Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.

Read more on APD

About Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

Read more on ARE